Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 616149, 10 pages
http://dx.doi.org/10.1155/2014/616149
Research Article

The Role of Intrinsic Pathway in Apoptosis Activation and Progression in Peyronie’s Disease

1Department of Bio-Medical Sciences, Anatomy and Histology Section, University of Catania, Via S. Sofia 87, 95123 Catania, Italy
2Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90100 Palermo, Italy
3Department G.F. Ingrassia Section of Anatomic Pathology University of Catania, 95123 Catania, Italy
4Department of Urology, School of Medicine Tor Vergata University of Rome, 00133 Rome, Italy
5University College London Hospital, London WC1E 6BT, UK
6Cranfield Health Cranfield University, MK43 0AL, UK
7Sava Perovic Foundation, Center for Genito-Urinary Reconstructive Surgery, 11000 Belgrade, Serbia
8Clinic of Urology, Clinical Center Nis, 18000 Nis, Serbia

Received 26 February 2014; Accepted 31 May 2014; Published 13 August 2014

Academic Editor: Ralf Herwig

Copyright © 2014 Carla Loreto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. H. Jordan, S. M. Schlossberg, and C. J. Devine, “Surgery of the penis and urethra,” in Campbell’s Urology, P. C. Walsh, A. B. Retik, E. D. Vaughan, and A. J. Wein, Eds., pp. 3376–3394, WB Saunders, Philadelphia, Pa, USA, 7th edition, 1998. View at Google Scholar
  2. M. B. Noss, N. S. Day, G. J. Christ, and A. Melman, “The genetics and immunology of Peyronie's disease,” International Journal of Impotence Research, vol. 12, supplement 4, pp. S127–S132, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. W. J. G. Hellstrom and T. J. Bivalacqua, “Peyronie's disease: etiology, medical, and surgical therapy,” Journal of Andrology, vol. 21, no. 3, pp. 347–354, 2000. View at Google Scholar · View at Scopus
  4. S. S. Gholami, S. S. Gholami, T. F. Lue, and T. F. Lue, “Peyronie's disease,” Urologic Clinics of North America, vol. 28, no. 2, pp. 377–390, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. O. U. Zorba, S. Sirma, G. Ozgon, E. Salabas, U. Ozbek, and A. Kadioglu, “Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea,” Advances in Clinical and Experimental Medicine, vol. 21, no. 5, pp. 607–614, 2012. View at Google Scholar · View at Scopus
  6. R. C. Dean and T. F. Lue, “Physiology of penile erection and pathophysiology of erectile dysfunction,” Urologic Clinics of North America, vol. 32, no. 4, pp. 379–395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. N. F. Gonzalez-Cadavid, T. R. Magee, M. Ferrini, A. Qian, D. Vernet, and J. Rajfer, “Gene expression in Peyronie's disease,” International Journal of Impotence Research, vol. 14, no. 5, pp. 361–374, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. N. F. Gonzalez-Cavid and J. Rajfer, “Mechanisms of disease: new insight into the cellular and molecular pathology of Peyronie's disease,” Nature Clinical Practice Urology, vol. 2, pp. 291–297, 2005. View at Google Scholar
  9. H. P. Ehrlich, “Scar contracture: cellular and connective tissue aspects in Peyronie's disease,” Journal of Urology, vol. 157, no. 1, pp. 316–319, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. K. T. McVary, “Peyronies disease,” in Proceedings of the American Urological Association Annual Meeting, Plenary Session 3, 2001.
  11. C. A. Anaheim and C. J. Davis, “The microscopic pathology of Peyronie's disease,” The Journal of Urology, vol. 157, pp. 282–284, 1997. View at Google Scholar
  12. W. J. G. Hellstrom and Y. R. Cockerham, “Intralesional injection therapy for Peyronie's disease,” Journal of Sexual Medicine, vol. 6, no. 7, pp. 1811–1814, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Munöz-Pinedo, “Sinaling pathway that regulate life and cell death: evolution of apoptosis in the contex of self-defence,” in Self and Nonself, C. López-Larrea, Ed., chapter 8, pp. 124–143, Springer, 2012. View at Google Scholar
  14. E. K. Rowinsky, “Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents,” Journal of Clinical Oncology, vol. 23, no. 36, pp. 9394–9407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Loreto, L. E. Almeida, M. R. Migliore, M. Caltabiano, and R. Leonardi, “TRAIL, DR5 and caspase 3-dependent apoptosis in vessels of diseased human temporomandibular joint disc. An immunohistochemical study,” European Journal of Histochemistry, vol. 54, no. 3, pp. 175–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Caltabiano, R. Leonardi, G. Musumeci et al., “Apoptosis in temporomandibular joint disc with internal derangement involves mitochondrial-dependent pathways: an in vivo study,” Acta Odontologica Scandinavica, vol. 71, no. 3-4, pp. 577–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Loreto, L. E. Almeida, P. Trevilatto, and R. Leonardi, “Apoptosis in displaced temporomandibular joint disc with and without reduction: An immunohistochemical study,” Journal of Oral Pathology and Medicine, vol. 40, no. 1, pp. 103–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. W. Fesik, “Insights into programmed cell through structural biology,” Cell, vol. 103, no. 2, pp. 273–282, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Loreto, G. Barbagli, R. Djinovic et al., “Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie's disease. A biomolecular study of apoptosis activation,” Journal of Sexual Medicine, vol. 8, no. 1, pp. 109–115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. H. Egydio and S. Sansalone, “Peyronie's reconstruction for maximum length and girth gain: geometrical principles,” Advances in Urology, vol. 2008, Article ID 205739, 9 pages, 2008. View at Publisher · View at Google Scholar
  21. G. Garaffa, S. Sansalone, and D. J. Ralph, “Penile reconstruction,” Asian Journal of Andrology, vol. 15, no. 1, pp. 16–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. NESBIT, “Congenital curvature of the phallus: report of three cases with description of corrective operation,” The Journal of Urology, vol. 93, pp. 230–232, 1965. View at Google Scholar · View at Scopus
  23. G. Musumeci, P. Castrogiovanni, C. Loreto, S. Castorina, K. Pichler, and A. M. Weinberg, “Post-traumatic caspase-3 expression in the adjacent areas of growth plate injury site: a morphological study,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15767–15784, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Loreto, A. Orlandi, A. Ferlosio et al., “Cryopreserved penile tunica albuginea for allotransplantation: a morphological and ultrastructural investigation,” Journal of Sexual Medicine, vol. 9, no. 9, pp. 2378–2388, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Ralph and S. Minhas, “The management of Peyronie's disease,” BJU International, vol. 93, no. 2, pp. 208–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. D. L. Vaux, S. Cory, and J. M. Adams, “Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells,” Nature, vol. 335, no. 6189, pp. 440–442, 1988. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Korsmeyer, “Bcl-2 initiates a new category of oncogenes: regulators of cell death,” Blood, vol. 80, no. 4, pp. 879–886, 1992. View at Google Scholar · View at Scopus
  28. X. M. Yin, Z. N. Oltvai, and S. J. Korsmeyer, “BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax,” Nature, vol. 369, no. 6478, pp. 321–323, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. N. Oltvai, C. L. Milliman, and S. J. Korsmeyer, “Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death,” Cell, vol. 74, no. 4, pp. 609–619, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. W. W. Wong and H. Puthalakath, “Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway,” IUBMB Life, vol. 60, no. 6, pp. 390–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Huppertz, H. Frank, and P. Kaufmann, “The apoptosis cascade—morphological and immunohistochemical methods for its visualization,” Anatomy and Embryology, vol. 200, no. 1, pp. 1–18, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Loreto, C. Galanti, R. Leonardi et al., “Possible role of apoptosis in the pathogenesis and clinical evolution of radicular cyst: an immunohistochemical study,” International Endodontic Journal, vol. 46, no. 7, pp. 642–648, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Vernet, M. G. Ferrini, E. G. Valente et al., “Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model,” Nitric Oxide, vol. 7, no. 4, pp. 262–276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. C. J. Davis, “The microscopic pathology of Peyronie's disease,” The Journal of Urology, vol. 157, no. 1, pp. 282–284, 1997. View at Publisher · View at Google Scholar
  35. C. J. Devine Jr., K. D. Somers, G. H. Jordan, and S. M. Schlossberg, “Proposal: trauma as the cause of the Peyronie's lesion,” Journal of Urology, vol. 157, no. 1, pp. 285–290, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. J. P. Jarow and F. C. Lowe, “Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction,” The Journal of Urology, vol. 158, no. 4, pp. 1388–1390, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. K. D. Somers and D. M. Dawson, “Fibrin deposition in Peyronie's disease plaque,” Journal of Urology, vol. 157, no. 1, pp. 311–315, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. A. W. Shindel, G. Lin, H. Ning et al., “Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix,” The Journal of Sexual Medicine, vol. 7, no. 6, pp. 2077–2085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. L. X. Young, A. J. Bella, D. B. O'Gorman, B. S. Gan, K. B. Lim, and G. B. Brock, “Protein biomarker analysis of primary Peyronie's disease cells,” The Journal of Sexual Medicine, vol. 7, pp. 99–106, 2010. View at Google Scholar
  40. N. F. Gonzalez-Cadavid and J. Rajfer, “Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy,” Nature Reviews Urology, vol. 7, no. 4, pp. 215–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Pardo, R. Barrios, V. Maldonado et al., “Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications,” The American Journal of Pathology, vol. 153, no. 3, pp. 833–844, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. M. G. Ferrini, T. R. Magee, D. Vernet, J. Rajfer, and N. F. González-Cadavid, “Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis,” Biology of Reproduction, vol. 64, no. 3, pp. 974–982, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. M. G. Ferrini, D. Vernet, T. R. Magee et al., “Antifibrotic role of inducible nitric oxide synthase,” Nitric Oxide, vol. 6, no. 3, pp. 283–294, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. T. J. Bivalacqua, E. K. Diner, T. E. Novak et al., “A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression,” Journal of Urology, vol. 163, no. 6, pp. 1992–1998, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. H. H. Davila, M. G. Ferrini, J. Rajfer, and N. F. Gonzalez-Cadavid, “Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease,” BJU International, vol. 91, no. 9, pp. 830–838, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Teramoto, A. Kiss, and S. S. Thorgeirsson, “Induction of p53 and Bax during TGF-β1 initiated apoptosis in rat liver epithelial cells,” Biochemical and Biophysical Research Communications, vol. 251, no. 1, pp. 56–60, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Lucattelli, B. Lunghi, S. Fineschi et al., “A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes,” The International Journal of Biochemistry & Cell Biology, vol. 40, no. 11, pp. 2638–2648, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. K. H. Jung, Y. Ryu, H. Lee et al., “A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques,” International Journal of Oncology, vol. 42, no. 6, pp. 2001–2008, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Gelbard, “Myofibroblasts and mechanotransduction: do forces in the tunica albuginea contribute to peyronie's disease?” Journal of Sexual Medicine, vol. 5, no. 12, pp. 2973–2976, 2008. View at Publisher · View at Google Scholar · View at Scopus